Stockreport

CERo Therapeutics Provides Shareholder Update

CERo Therapeutics Holdings, Inc.  (CERO) 
PDF Ongoing activities, including new engagement to relist on Nasdaq, new board member, continued advancement of Phase 1 trial into MDS patients, strategic engagement, and c [Read more]